EIAgen ANA screen

brief description

The detection of Anti-Nuclear Antibodies (ANA) has long been an important tool in the diagnosis of systemic rheumatic diseases. Until recently the majority of ANA testing had been almost exclusively conducted by immunofluorescence assays (IFAs). This had the advantage that highly trained operators could not only determine whether a sample is ANA positive, but could sometimes suggest which ANA are present. The ELISA systems now available allow the operator to screen out the ANA negatives and then go on through a cascade of tests to determine, semi-quantitatively, precisely which antibodies are present.

intended use

The EIAgen ANA Screen is an Enzyme-linked immunosorbent assay method for the quantitative determination of specific IgG autoantibodies to anti-nuclear antigens in human serum.